Introduction: The vital importance of engaging in physical activity for the maintenance and improvement of health is undeniable. The advent of digital technology has significantly enhanced the encouragement of physical activity (PA) through numerous interventions. Our study's goal is to examine the usage and prescription practices of mobile applications and fitness trackers by doctors operating in the private sector.
Methods: cross-sectional study, which targeted doctors in the private sector, whether general practitioners or specialists was carried out in January and February 2024, A paper questionnaire was distributed to the doctors' offices.
Results: the mean age was 44.3±11.7 years, 77% of doctors are physically active, the prevalence of use of mobile applications and fitness trackers among private sector physicians for improving and monitoring their physical activity was 32% with a CI ranging from [26-40] % and only 15% recommend mobile apps to patients. This reluctance was attributed to the applications' lack of customization and the challenges patients faced in using them.
Conclusion: In our research, we found that doctors rarely utilized mobile applications to enhance their practice of physical activity and were hesitant to recommend them to their patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3233/SHTI240440 | DOI Listing |
Background: Alzheimer's disease (AD) agitation is a distressing neuropsychiatric symptom characterized by excessive motor activity, verbal aggression, or physical aggression. Agitation is one of the causes of caregiver distress, increased morbidity and mortality, and early institutionalization in patients with AD. Current medications used for the management of agitation have modest efficacy and have substantial side effects.
View Article and Find Full Text PDFBackground: Alzheimer's disease is the most dreaded multifactorial neurological illness for which there is currently no known treatment. Although the exact cause of AD is still unknown, several factors related to lifestyle, genetics, and environment are known to have a significant role in the disease's development. Alzheimer's disease is characterized by neuronal loss, neurofibrillary tangles, and senile plaques.
View Article and Find Full Text PDFBackground: The LatAm-FINGERS trial marks a pioneering initiative as the first non-pharmacological clinical trial encompassing participants from 12 Latin American countries, including Argentina, Brazil, Bolivia, Chile, Colombia, Costa Rica, Ecuador, Dominican Republic, Mexico, Peru, Puerto Rico, and Uruguay. This initiative represents a significant advancement in promoting inclusivity and diversity in clinical trial recruitment, particularly in underserved populations.
Method: The LatAm-FINGERS trial is a multicenter randomized clinical trial evaluating a lifestyle intervention tailored for the Latin American population.
Alzheimers Dement
December 2024
National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Background: The effectiveness of multimodal lifestyle interventions to prevent dementia is being validated. Since a relatively long period (∼2 years) is required for manifesting an impact on cognitive function, the exploration of an alternative marker that exhibits changes within a comparatively brief duration, thereby prognosticating future alterations in cognitive function, is needed. The decline in gait function is associated with cognitive impairment and is also a predictor of future cognitive decline.
View Article and Find Full Text PDFBackground: Irisin is an exercise-induced myokine that elicits beneficial effects of exercise in fat, bone, and the brain. Previous work suggests that extracellular heat shock protein 90a (Hsp90a) mediates irisin-receptor interaction in bone and fat. Despite this, it remains unclear if Hsp90a is necessary for irisin signaling in the brain.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!